Johnson & Johnson announced the long-awaited soft tissue surgical robot at its Q3 meeting this year---OttavaLatest News --- IDE Clinical Study Application Submitted to FDA.
Executive Evaluation
"Johnson & Johnson's strong performance in the third quarter reflects our unique business scope and commitment to achieving the next wave of healthcare innovation. This quarter, we advanced the regulatory approvals for TREMFYA and RYBREVANT, submitted an IDE application for our general surgery robotic system Ottava, and launched Velys Spine and the Shockwave E8 IVL catheter, further strengthening our confidence in both near-term and long-term growth objectives."
---Joaquin Duato, Chairman and CEO of Johnson & JohnsonSoft tissue surgical robots, as the crown jewel of surgical robots,Intuitive Surgical can become the global leader in medical device market capitalization solely with the da Vinci surgical robot, surpassing the leading medical device company Medtronic (over 50 billion USD), and this lead continues to expand.VisibleSoftTissue SurgeryMachineThe high market value of personnel also gradually indicates the market's high recognition of the da Vinci robot, especially with the launch of its revolutionary surgical robot.Da VinAfter CI 5, it forms a technological dimensional reduction attack on competitors.It is precisely because of the recognition of the market value of soft tissue surgical robots, also known as the battleground for major giants in the abdominal (thoracic) surgery field. Medtronic, Johnson & Johnson, Storz and others have successively entered the market, but these entrants have notIntuitive Surgical does not pose any real effective threat.For example, Hugo, since obtaining CE approval in 2021, has also initiated commercialization, but its sales volume is relatively low compared to...IntuitivThe surgical results are negligible and far from meeting expectations. The registration progress in countries and regions such as the United States is extremely slow, and talent-related issues have also arisen.Johnson & Johnson is even considered a joke in the field of soft tissue surgical robotics. Back in the day, Johnson & Johnson collaborated with Google to developSoftTissue SurgeryMachinePeople, once thought to be disruptive to the industry.Unfortunately, different fields are like different mountains, and Google's understanding of clinical aspects is too shallow, leading toOttavaDifficult birth. Google also withdrew from the project, and later Johnson & Johnson spent a huge amount to acquire it.Auris Health, and inviteIntuitivFounder of e SurgicalFrederic Moll JoinsOttavaProject Team. HoweverOttavaStill plagued by numerous issues, causing continuous delays in the project, which at one point made Johnson & JohnsonOttavaKeep it under wraps. For this reason, Johnson & Johnson had to look externally.Investment CreationNew surgical robot company Moon Surgical avoids being marginalized in the soft tissue surgical robot field.Despite more than two years of development and preparation,OttavaFinally submitted the IDE application to the FDA, allowingOttavaThe project is on track. If things go quickly, it could be launched by the end of the year or early next year.OttavaClinical research, and even has the opportunity to catch up with Hugo's progress in the United States.
OttavaA surgical robot with four mechanical arms, capable ofFour robotic arms are integrated into a standard-sized operating table.This invisible structural design allows the robotic arm to be fixed on the operating table when needed, and stored under the operating table when not in use.The design eliminates mobility and collaboration barriers in robotic operating rooms, offering surgical teams the freedom and flexibility to adapt to clinical workflows and personalized patient needs.OttavaInvisible ArchitectureDesignSimilar toCMR SurgicalTheVersius。OttavaAdopting a zero-footprint design to increase operating room space and improve operating room workflow.OttavaThe robotic arm can be taken out and fixed on the operating table when needed, and removed when not in use.Stored under the operating table during the procedure.
OttavaThe "dual-motion" function - the unified movement of the operating table and robotic arm - is designed to meet critical clinical needs for the surgical team during procedures, such as the ability to reposition the patient without interrupting the surgery.
EthiconAs part of Johnson & Johnson Medical Devices, Ethicon has made significant contributions to surgery for over 100 years, from creating the first sutures to revolutionizing surgery with minimally invasive procedures.EthiconDedicated to shaping the future of surgery, our commitment is built on helping address the world’s most pressing healthcare challenges and improving and saving more lives. Through Ethicon’s surgical technologies and solutions, including sutures, staplers, energy devices, trocars, and more, as well as our commitment to treating serious conditions like obesity globally, we deliver innovations that transform lives.
